Drug Type Small molecule drug |
Synonyms Meprobamate (JAN/USP/INN), Meprobamic acid + [10] |
Target |
Action agonists |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (28 Apr 1955), |
Regulation- |
Molecular FormulaC9H18N2O4 |
InChIKeyNPPQSCRMBWNHMW-UHFFFAOYSA-N |
CAS Registry57-53-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00376 | Meprobamate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anxiety Disorders | China | 01 Jan 1981 | |
Epilepsy | China | 01 Jan 1981 | |
Muscle Rigidity | China | 01 Jan 1981 | |
Sleep Initiation and Maintenance Disorders | China | 01 Jan 1981 |